Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 26 citing Hill: The ADVANTAGE seeding trial: a review of internal documents. (0.12 sec) 

[PDF] Conflict of Interest in Medical Research, Education, and Practice


B Lo, MJ Field - … , DC: National Academies, Institute of Medicine, 2009 - kurse.fh-regensburg.de
Visit the National Academies Press online, the authoritative source for all books from the National
Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the
National Research Council: • Download hundreds of free books in PDF • Read thousands ...
Cited by 4 - Related articles - View as HTML - All 2 versions

'Ghostbusting'at Blood


CE Dunbar, MS Tallman - Blood, 2009 - bloodjournal.hematologylibrary.org
Recently Blood received an unsolicited review article authored by a prominent clinical investigator
addressing a timely topic. The reviewers described the paper as well-written, informative, and
balanced. However, one reviewer noted with concern that a person thanked in the ...
Cited by 2 - Related articles - All 2 versions

[PDF] Technology Assessment


H Scan, TO WHAT, EDOC IN, TP PAYMENT - mannen.typepad.com
Prepared for: Agency for Healthcare Research and Quality 540 Gaither Road Rockville, Maryland
20850 ... Horizon Scan: To What Extent Do Changes in ... Third-Party Payment Affect Clinical
Trials and the ... Amy P. Abernethy, MD Nancy M. Allen Lapointe, PharmD Jane L. ...
Cited by 1 - Related articles - View as HTML - All 3 versions

Shifting Terrain in the Regulation of Off-Label Promotion of Pharmaceuticals


MM Mello, DM Studdert, TA Brennan - The New England Journal of …, 2009 - nejm.highwire.org
In regulating the promotion of unapproved, or off-label, uses of approved drugs, the Food and
Drug Administration (FDA) has sought to strike a balance between supporting the ability of
phy- sicians to prescribe according to their best clini- cal judgment and preventing drug ...
Cited by 1 - Related articles - All 3 versions

[PDF] Agenzia Italiana del Farmaco


AP Brizi, U Filibeck, K Kangaspunta, AL O'Neil - unicri.it
The views expressed are those of the authors and do not necessarily reflect the views of UNICRI
and AIFA. The Authors are not responsible for the use that might be made of the information contained
in this Report. Contents of this Report may be quoted or reproduced, provided that the ...
Related articles - View as HTML - All 2 versions

Conflicts of Interest, Authorship, and Disclosures in Industry-Related Scientific …


LJ Hirsch - Mayo Clinic Proceedings, 2009 - mayoclinicproceedings.com
In recent years, Mayo Clinic Proceedings has published a variety of articles dealing with
important, broad-reaching matters of societal interest that impact medicine and patient care. Topics
included ideal physician behaviors, gender and medical career mentoring, advance ...
Related articles - All 10 versions

[PDF] Contradictory Actions on Off-Label Use of Prescription Drugs? The FDA and CMS …


O January - my.amcp.org
Page 1. 161 Journal of Managed Care Pharmacy JMCP March 2009 Vol. 15, No.
2 www.amcp.org On January 15, 2009, the US Justice Department posted a notice
on its website that Eli Lilly and Company had agreed to pay ...
Related articles - View as HTML - All 3 versions

Fact or Fiction: The Need for Independent Pharmaceutical Policy Research

- nih.gov
S Keyhani, A Federman - Journal of General Internal Medicine, 2009 - Springer
Page 1. Fact or Fiction: The Need for Independent Pharmaceutical Policy Research
Salomeh Keyhani, MD, MPH 1,2,3 and Alex Federman, MD, MPH 3 1 James J. Peters
Veterans Administration Medical Center, Bronx, NY, USA; ...
Related articles - All 4 versions

Good publication practice for communicating company sponsored medical …


C Graf, WP Battisti, D Bridges, V Bruce-Winkler, JM … - British Medical Journal, 2009 - bmj.com
Authors and presenters are responsible for how medical research is interpreted and
communicated. Often their work is the product of collaborations with other individuals (such as
clinical investigators, biostatisticians, and professional medical writers) from around the ...

Seeding Trials: Just Say “No”


NTAG Tolerability - Annals of Internal Medicine - Am Coll Physicians
Why would a drug company go to the expense and bother of conducting a trial involving hundreds
of practitioners—each recruiting a few patients—when a study based at a few large medical centers
could accomplish the same scientific purposes much more efficiently? The main point of ...
Related articles


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google